Insider · CIK 0002049757
Herrmann Ken
Reports to the SEC for 1 company · BOSTON, MA
Transactions
9
Companies
1
Filings
2
CIK
0002049757
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-07-20 | AKTSAktis Oncology, Inc.M Exercise/Conversion | +$280.48 |
| 2026-07-20 | AKTSAktis Oncology, Inc.M Exercise/Conversion | +$2,578.5 |
| 2026-07-20 | AKTSAktis Oncology, Inc.S Sale | −$86.1K |
| 2026-07-20 | AKTSAktis Oncology, Inc.S Sale | −$33.2K |
| 2026-07-20 | AKTSAktis Oncology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2026-07-20 | AKTSAktis Oncology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2026-07-17 | AKTSAktis Oncology, Inc.M Exercise/Conversion | +$245.2 |
| 2026-07-17 | AKTSAktis Oncology, Inc.S Sale | −$77.3K |
| 2026-07-17 | AKTSAktis Oncology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
Recent filings
- 4Herrmann Ken0001193125-26-310991SEC(opens sec.gov)
- 4Herrmann Ken0001193125-26-309115SEC(opens sec.gov)
Companies
Address
C/O AKTIS ONCOLOGY, INC. 17 DRYDOCK AVENUE, SUITE 17-401
BOSTON, MA, 02210